aod9604 clinical trials fat loss efficacy side effects AOD 9604: Peptide Claims vs Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH's effects. The clinical question Product Insulin-like growth factor-1 deficiency Color:510 Deep

aod9604 clinical trials fat loss efficacy side effects AOD 9604: Peptide Claims vs Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH's effects. The clinical question Product Insulin-like growth factor-1 deficiency Color:510 Deep

Insulin-like growth factor-1 deficiency and metabolic syndrome | Journal of Translational Medicine | Springer Nature Link

doi: 10.1038/s41375-020-0810-4 24 ZhuCSongZWangASrinivasanSYangGGrecoRet al

Product

Color:510 Deep

The specificity for visceral fat over subcutaneous fat is believed to be due to the higher density of lipolytic receptors in visceral adipose deposits